OPEN
INNOVATION

We aim to achieve innovation in R&D
through partnerships with the
global community.

Samyang Holdings implements various partnership models such as joint and sponsored research and development, licensing in/out, M&A, investment, and joint venture to develop therapeutics using SENS™, our unique gene delivery technology.

  • Companies or academia, research or other related institutes that have nucleic-acid-based vaccine and gene therapy technologies

  • Companies or academia, research or other related institutes that have new polymers and lipids

  • Companies or academia, research or other related institutes with expertise in process development

Inquiries
TOP

We refuse unauthorized email collection

Close

We refuse the unauthorized collection of the email addresses on this website using email collection programs or other technical devices. Please note that any violation will be subject to criminal penalties in accordance with the Act on Information and Communications Network.

Posted on March 28, 2023

Cookie Popup Close
Manage Cookies

This site uses cookies.
By continuing to browse the site,
you agree to the use of cookies.

Privacy Policy Accept